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Objectives: Disturbed endogenous pain modulation is likely one of
the mechanisms underlying central hypersensitivity and might be
a contributing factor for the development and maintenance of
chronic pain. To our knowledge, no study has investigated
endogenous pain modulation in both acute and chronic low back
pain (LBP). We tested the hypothesis that endogenous pain
inhibition is impaired in patients with acute and chronic LBP.
Materials and Methods: We evaluated 40 patients with acute LBP,
34 patients with chronic LBP and 30 pain-free controls for their
conditioned pain modulation (CPM), with pressure pain tolerance
and cold pressor as test and conditioning stimulus, respectively.
Measurements were repeated up to 10 minutes after cold pressor
test.
Results: There was no diﬀerence in CPM among the groups
immediately after cold pressor test. However, the decline in CPM
eﬀect was signiﬁcantly faster in chronic and acute LBP patients
than in controls, with no evidence for diﬀerences between pain
groups.
Discussion: The present study provides evidence for some alter-
ations of endogenous modulation in both acute and chronic LBP.
CPM was still detected in both patient groups, indicating that
endogenous modulation, although eﬀective for a shorter duration,
is partially functioning in patients with LBP.
Key Words: conditioned pain modulation, acute low back pain,
chronic low back pain
(Clin J Pain 2016;32:116–121)
The central nervous system is capable to modulate signalscoming from peripheral tissues, leading to either
ampliﬁcation or attenuation of the nociceptive input.1 One
important aspect of central pain modulation is endogenous
inhibition, as its impaired eﬃciency may be a determinant
of symptoms in pain patients. In humans, 1-test paradigm
to evaluate the endogenous pain modulatory system is
conditioned pain modulation (CPM), which occurs when
the response to a painful test stimulus is inhibited by an
additional conditioning painful stimulus.2
Disturbed CPM is likely one of the mechanisms under-
lying central hypersensitivity and might be 1 contributing
factor for the development and maintenance of chronic pain.
Patients with chronic low back pain (LBP) display decreased
pain thresholds after stimulation of nonpainful tissues and
enlargement of the areas of referred pain,3–5 which is strongly
suggestive for widespread central hypersensitivity. Although
hypersensitivity has been documented, the mechanisms
underlying exaggerated pain responses in acute and chronic
LBP are unclear. One of these mechanisms may be deﬁcient
endogenous pain modulation. Most studies have focused on
chronic pain conditions, but deﬁcient pain modulation could
also be present in the acute phase. Furthermore, most studies
have assessed CPM at 1 time-point, and information on its
time course after cessation of the conditioning stimulus is
sparse.
The hypothesis of this study was that endogenous pain
inhibition is impaired in patients with acute and chronic
LBP. We evaluated the inhibitory eﬀect not only immedi-
ately after the conditioning stimulus, but also 3, 5, and
10 minutes after its cessation. The results are expected to
improve our knowledge on the role of central modulatory
mechanisms in the pathophysiology of LBP and possibly




Consecutive patients with acute LBP were asked to
participate in the study at the mediX practice network of
Bern, Switzerland. These patients were part of a still run-
ning prospective cohort study on acute LBP. During the
same period of time, consecutive patients with chronic LBP
were recruited at the Pain Division of the Department of
Anesthesiology and Pain Therapy of the University Hos-
pital of Bern, Switzerland. These patients were part of a
case-control study.6 Pain-free controls were recruited at the
University of Bern by advertisement. The period of data
acquisition was from January 1, 2009 until October 31,
2011.
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Inclusion criteria for the acute LBP group were pain
lasting for no longer than 4 weeks and LBP at the time of
testing with an intensity Z3 using a 10 cm visual analog
scale (VAS), whereby 0=no pain and 10=worst pain
imaginable. Exclusion criteria were any history of chronic
LBP and the presence of any type of chronic pain. Inclusion
criteria for the chronic LBP group were daily LBP for at
least 6 months duration and LBP at the time of testing with
an intensity of VASZ3. Exclusion criterion was the pres-
ence of any other type of chronic pain. For the pain-free
controls the inclusion criterion was absence of any acute or
chronic painful condition.
Exclusion criteria for all groups were deﬁned as
inability to understand the tests, lacking knowledge of
German language, radicular pain (as deﬁned by leg pain
associated with an MRI ﬁnding of a herniated disk or
foraminal stenosis with contact to a nerve root), neuro-
logical conditions potentially aﬀecting sensory function
(ie, polyneuropathy, diabetes mellitus, or alcohol abuse),
pregnancy (ruled out by pregnancy test), breast-feeding,
intake of oral contraceptives or hormones, intake of opioids
and antidepressants during the previous 2 weeks, and
intake of other analgesics or drugs known to modulate pain
during 48 hours before testing.
Age, sex, and body mass index were recorded for
descriptive purposes. The studies were approved by the
local ethics committee (KEK no. 103/2008-107/04). Patients
and controls gave written informed consent.
Assessments of CPM
General Aspects of Assessments
The body side with the higher intensity of pain was
determined in patients who had unequal pain intensity on
the 2 body sites, and was chosen for the application of
pressure stimulation. In case of bilateral pain of equal
intensity and in the control group, the side of application of
pressure stimulation was randomly selected. We assessed
thresholds for pain tolerance before and 0, 3, 5, and
10 minutes after the cold pressor test (CPT). The response
to the test stimulus was the pressure pain tolerance
threshold (PPTT) measured at the ipsilateral 2nd toe,
before and immediately after conditioning stimulus (CPT),
which was applied to the contralateral hand. CPM was
calculated as the absolute diﬀerence of pressure tolerance
thresholds after-before CPT.
Pressure Stimulation
The test was applied at the center of the pulp of the
2nd toe. PPTT was measured with an electronic pressure
algometer (Somedic, Ho¨rby, Sweden). The pressure was
increased from 0 at a rate of 30 kPa/s to a maximum
pressure of 1000 kPa. PPTT was deﬁned as the point at
which the participant felt pain as intolerable. The partic-
ipants were instructed to press a button when this point was
reached. The algometer displays the pressure intensity at
which the button is pressed. If patients did not press the
button at 1000 kPa, this value was considered as pain tol-
erance threshold, although the tolerance level has not been
reached.
At the beginning, the test was performed several times at
the 2nd ipsilateral ﬁnger for training purposes until the par-
ticipant was familiar with the procedure. These measurements
were not used for the data analysis. Then, 3 assessments for
PPTT were made at the 2nd toe, and the average of these 3
measurements was calculated for the analysis of PPTT.
Cold Pressor Test
The contralateral hand was immersed in ice saturated
water (0.7±11C). Perceived pain intensity was con-
tinuously rated with an electronic VAS coupled to a pen
recorder. Participants were instructed to keep their hand in
the cold water for a maximum of 2 minutes. The device
consisted of a container separated by a mesh screen into an
outer and an inner part. The mesh screen prevents direct
contact between the ice (placed in the outer part) and the
hand of the participant (placed in the inner part). The water
was regularly stirred to maintain the temperature in the
inner part near to 0.71C, as monitored by a thermometer
with a digital display (±0.11C). Patients placed their hand,
wide open and up to the wrist, into the inner part of the
container. They were asked to keep it under water for a
maximum time of 2 minutes. If pain was intolerable before
2 minutes had elapsed, the participant could withdraw the
hand and the elapsed time was noted. The area under the
curve of pain intensity over the 2-minute period was
calculated.
CPM
At the very same time as the hand was withdrawn from
the ice water, a single assessment of PPTT at the 2nd
toe was made as described above. The diﬀerence in PPTT
after-before the CPT was then calculated and considered
as a measure of CPM. Positive values would indicate
increase in PPTT and, therefore, functioning endogenous
pain inhibition. This parameter, recorded immediately after
hand withdrawal (time 0), was the primary outcome of
this study. In addition, PPTT was measured 3, 5, and




The 3 groups were compared using the w2 test for the
binary variable and 1-way analysis of variance for con-
tinuous variables.
Primary and Secondary Outcomes
Our primary hypothesis was that pain inhibition dif-
fers between the 2 groups of LBP patients and pain-free
controls immediately after the CPT. The secondary
hypothesis was that CPM diminishes faster in the 2 patient
groups than in the control group.
We tested these hypotheses in a repeated measure
linear-mixed model using restricted maximum likelihood
estimation. The PPTT measurement immediately, ?3, 5, and
10 minutes after the CPT was deﬁned as dependent varia-
ble, the patient group category and time-point category as
independent variables. To study diﬀerences in the decrease
of CPM between groups over time, we introduced inter-
action terms between groups and time-points. The model
was adjusted for the baseline value of PPTT, withdrawal
time out of the cold water, age, sex, and body mass index.
To account for the correlation of repeated measures within
participants, we introduced a random eﬀect at the partic-
ipant level and applied a within-participant autoregressive
(AR 1) covariance structure. As we control the outcome
variable (PPTT measured after the CPT) for the baseline
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PPTT measured before the CPT, we actually model diﬀer-
ences in PPTT before and after the cold water test, that is,
the CPM. Therefore, the resulting beta-coeﬃcients can
directly be interpreted as eﬀects on CPM.
Sample Size Considerations
Sample size considerations were based on the inhib-
itory eﬀect of the CPT on the PPTT, assuming a SD of the
inhibitory eﬀect of 100 kPa in all 3 groups. A sample size of
30 participants per group provides a power of 87% to
detect a diﬀerence in inhibition of 80 kPa at a 2-sided alpha
of 0.05. All analyses were performed using Stata, Release 12
(Stata Corp LP, College Station, TX).
RESULTS
During the period of data collection of 40 patients
with acute LBP, 34 chronic LBP patients, and 30 pain-free
controls were recruited. Data were complete for all
participants.
Baseline Characteristics and Descriptive
Variables
Patients with acute and chronic LBP had a mean
duration of pain of 1.8 (±1.0) weeks and 84 (±105)
months, respectively. The mean pain intensity on a numeric
rating scale from 0 to 10 was 5.2 (±1.5) for patients with
acute LBP and on a VAS from 0 to 10 was 5.1 (±1.4) for
chronic LBP patients. Demographic characteristics are
reported in Table 1. The groups diﬀered only in age, with
the chronic LBP group being older than the other 2 groups.
PPTT at all time-points and withdrawal time of the
CPT are reported in Table 2. The PPTT varied signiﬁcantly
among all groups at all the time-points, with higher values
in pain-free controls compared with both patient groups
(Table 2 and Figure 1). Withdrawal time from ice water did
not vary signiﬁcantly among groups (P=0.30). The per-
cent of participants who reached the pain tolerance to the
CPT before the 2-minute limit was 87.5, 85.2, and 83.3 in
the acute LBP, chronic LBP, and control groups,
respectively.
Primary Aim
The mean diﬀerence in PPTT between measurement
made immediately after and before the CPT (inhibitory
eﬀect) was: 164 kPa (95% conﬁdence interval [CI], 120-207)
in acute LBP, 161 kPa (95% CI, 93-228) in chronic LBP,
and 132 kPa (95% CI, 91-173) in controls (Fig. 2). A
repeated measures mixed model did not show any explan-
atory eﬀect of patient group on CPM immediately after the
CPT as compared with the control group. The eﬀect on
CPM was 15.7 kPa (95% CI, 51.6 to 83.1; P=0.65) in
chronic LBP and 5.6 kPa (95% CI, 69.2 to 58.0;
P=0.83) in acute LBP patients (Table 3).
Secondary Aims
The inhibitory eﬀect decreased with time. Three
minutes after the CPT, the values were 67 kPa (95% CI, 35-
100) in acute LBP, 65 kPa (95% CI, 14-115) in chronic
LBP, and 103 kPa (95% CI, 67-139) in controls (Fig. 2).
Three minutes after the CPT, patients with acute LBP
showed a signiﬁcantly smaller CPM than controls (adjusted
eﬀect of 72.6 kPa; 95% CI, 136.2 to 9.0; P=0.03).
The CPM was also smaller in patients with chronic LBP
than in controls, but this eﬀect was not statistically sig-
niﬁcant: 50.9 kPa (95% CI, 118.2 to 16.5; P=0.14).
There were no signiﬁcant explanatory eﬀects of groups on
CPM 5 and 10 minutes after the CPT.
The time course of the inhibitory eﬀect is illustrated
in Figure 2. According to the repeated measures mixed
model, patients with acute and chronic LBP exhibited a
signiﬁcantly steeper decline of the inhibitory eﬀect between
0 and 3 minutes than pain-free patients, meaning that the
inhibitory eﬀect diminished faster in both patient groups
compared with the control group (eﬀect on decline in
chronic LBP patients compared with controls: 66.7 kPa;
95% CI, 119.9 to 13.5; P=0.01; in acute LBP patients
compared with controls: 67.0 kPa; 95% CI, 118.3 to
15.7; P=0.01; Table 3).
We additionally tested for associations between
inhibitory eﬀects at the time immediately after the CPT and
pain duration as well as pain intensity in both patient
groups. We found only weak and mainly nonsigniﬁcant
correlations, suggesting that patients with longer lasting
and more intense pain might exhibit smaller inhibitory
eﬀects (Figs. 3, 4).
DISCUSSION
Main Findings
In the present study, both patient groups and controls
displayed a CPM eﬀect, as PPTTs increased after CPT.
There was no overall diﬀerence in CPM among the groups
immediately after CPT, when calculated as diﬀerence after-
before or as percent of change. However, the decline in
CPM eﬀect was signiﬁcantly faster in chronic and acute
LBP patients than in controls, which indicates that the
endogenous inhibitory system can be less eﬃcient in chronic
and acute LBP patients. There was no evidence to suggest
that acute and chronic LBP patients diﬀered in their CPM
eﬃcacy.
CPM in Low Back Pain
Previous studies have found hyperalgesia and reduced
endogenous pain modulation in chronic pain, as assessed by
mechanical7–9 or thermal10 experimental pain modalities.
This has been detected in diﬀerent chronic pain conditions,
such as osteoarthritis,7,9 irritable bowel syndrome, or
TABLE 1. Demographic Characteristic of Participants
Acute Low Back Pain
(n=40)




Age 41.4 (12.5) 50.8 (14.0) 37.4 (10.9) <0.001
Sex (females) (n [%]) 16 (40) 17 (50) 16 (53) 0.499
BMI 24.2 (3.3) 26.1 (4.1) 25.1 (3.6) 0.077
Age and BMI are presented as mean (SD). Sex is presented as number (%) of females.
BMI indicates body mass index (kg/m2).
Mlekusch et al Clin J Pain  Volume 32, Number 2, February 2016
118 | www.clinicalpain.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2016 Wolters Kluwer Health, Inc. All rights reserved.
temporomandibular disorders.10 Hyperalgesia can predict a
large proportion of the variance of clinical pain intensity in
chronic musculoskeletal pain patients.11
The literature on CPM in chronic LBP is sparse. A
recent review12 found only 1 study, not supporting an
alteration in CPM.13 This conﬁrms our assumption that
measuring the time course may provide more information
than single assessments.
Few studies have been performed on CPM in acute
pain, and we are not aware of investigation on CPM in
acute LBP. Interestingly, our results indicate that an
alteration in endogenous modulation is likely present
already in the acute phase of LBP. We did not ﬁnd evidence
for a more severe alteration of CPM in chronic LBP,
indicating that changes in endogenous modulation may be
equally important in acute and chronic pain conditions.
The mechanisms underlying dysfunctional CPM are diﬃ-
cult to investigate in humans. Studies that correlate CPM
with brain processes have revealed modiﬁcations in the
activation of diﬀerent brain areas14 and in the functional
connectivity of the descending inhibitory system.15 The
origin of these changes, however, remains unclear.
Clinical Significance of CPM
An intriguing question is whether those patients dis-
playing an alteration in CPM in the acute phase are more
prone to develop chronic LBP. In a recent exploratory
study, we found no evidence for an association between
CPM, measured during the course of chronic pain, and
intensity of chronic LBP at follow-up.16 Another study on
acute LBP failed to demonstrate a predictive value of CPM
for the development of chronic LBP.17 This is in contrast to
the ﬁnding of a predictive value of CPM measures in
chronic postthoracotomy pain.18 Possibly, we have not yet
identiﬁed the type of CPM paradigm that most closely
reﬂects alterations in central modulatory processes. Lack of
information on the optimal methodology to assess CPM
prevents conclusions on the prognostic ability of endoge-
nous pain modulation.
Another important issue is the correlation between
CPM and intensity of LBP. Obviously, pain intensity
depends on many factors and CPM is not expected to
explain a large part of the complex experience of pain. Few
studies have addressed this issue. The most recent one did
not ﬁnd a statistically signiﬁcant correlation between CPM
and intensity of LBP; however, a composite score that
included CPM and other parameters of pain sensitivity
correlated signiﬁcantly with pain intensity.19
It is important to note that both patient groups displayed
an increase in PPTTs after conditioning stimulus; the mean
diﬀerences between patients and controls were modest and not
present at all time-points. Thus, we cannot make the general-
ized statement that patients with LBP have impaired endoge-
nous modulation. It is more likely that a subset of patients
display such altered central pain processing, but in the absence
of normative data it is hard to identify these patients
individually. Furthermore, our data do not support the view
that altered CPM is a major determinant of hyperalgesia and
pain in this patient population.
TABLE 2. Pain Assessments in the 3 Groups
Acute Low Back Pain
(n=40)




Pressure pain tolerance threshold (kPa)
Before CPT 388.6 (136.3) 407.8 (178.6) 548.8 (183.6) <0.001
0min after 552.2 (182.7) 568.5 (238.3) 681.0 (190.6) 0.025
3min after 456.0 (144.3) 472.7 (195.7) 651.8 (202.1) <0.001
5min after 460.3 (138.5) 464.1 (211.1) 628.7 (195.5) <0.001
10min after 450.0 (140.8) 473.3 (223.5) 601.5 (188.5) 0.003
Cold pressor test
Tolerance time (s) 49.6 (34.3) 53.9 (36.8) 62.8 (33.4) 0.296
AUC (mms) 9460 (1522) 8833 (2427) 8797 (2038) 0.284
Data are presented as mean (SD).
AUC indicates area under the curve; CPT, cold pressor test.
FIGURE 1. Pressure pain tolerance before 0, 3, 5, and 10 minutes
after the cold pressor test. The mean values with 95% confidence
intervals are presented.
FIGURE 2. Pain modulation, calculated as the difference in
pressure pain tolerance after-before cold pressor test at 0, 3, 5,
and 10 minutes. The mean values with 95% confidence intervals
are presented.
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Time Course of CPM
In a recent review Pud et al2 concluded that the CPM
eﬀects fade gradually with time, and therefore simultaneous
application of conditioning and test stimuli would be
appropriate. In 1 study, the inhibitory eﬀect on pressure
pain thresholds after injection of hypertonic saline into the
tibialis anterior muscle lasted for up to 15 minutes.20 Lewis
et al21 found CPM to return to baseline after 15 minutes,
using ice water or ischemic arm test as conditioning stimuli.
In our investigation, there was no signiﬁcant diﬀerence in
CPM among the groups immediately after the CPT. If we
had limited our testing procedure to an assessment imme-
diately after cessation of the conditioning stimulus, we
would have obtained only negative results. Our results
therefore suggest that repeating the test stimulus over time
can increase the chance of detecting alterations in endoge-
nous pain modulation.
Limitations of the Study
A limitation of this study is the diﬀerence in average
age in the 3 groups. However, the analysis was adjusted for
this factor, limiting the likelihood of biased results. The
complete time course of CPM is unclear, as the PPTTs were
still elevated at the last assessment, made at 10 minutes.
Because of the lack of a control session within groups, it is
diﬃcult to evaluate the contribution of habituation to the
CPM eﬀect. We evaluated CPM using only 1-test modality,
that is, the CPT on the upper arm. We cannot rule out that
using other methods would lead to diﬀerent results.
In comparison with other studies we used temperatures
around 0.71C for our ice water test. The low temperature can
be explained by the method of producing the ice water. Here, it
has to be taken into account, that diﬀuse noxious inhibitory
control should be more eﬃcient the lower the temperatures
are.22 Further a maximum of pain could not be achieved
within 2 minutes in some patients. A limit of this study is, that
the method of producing ice water is not comparable with
other studies and therefore cannot be used for meta-analysis.
Conclusions
In conclusion, the present study indicates a shorter
duration of endogenous pain inhibition in patients with
FIGURE 3. Association of the inhibitory effect immediately after
the cold pressor test with pain intensity in acute low back pain
patients. Scatter plot with a linear regression line, an associated
95% confidence interval, and P-value. The Spearman correlation
is 0.27 (P=0.10). For the association with pain duration, the
Spearman correlation is 0.17 (P=0.30, graph not shown).
FIGURE 4. Association of the inhibitory effect immediately after
the cold pressor test with pain duration in chronic low back pain
patients. Scatter plot with a linear regression line, an associated
95% confidence interval, and P-value. The Spearman correlation
is 0.35 (P=0.046). For the association with pain intensity, the
correlation is 0.08 (P=0.67, graph not shown).
TABLE 3. Effects (Beta-coefficients) From a Repeated Measure
Mixed Model With 95% Confidence Intervals and P-values
Eﬀect on CPM
(95% CI) (kPa) P
Group (eﬀects refer to the time-point immediately [0min] after cold
pressor test)
Pain-free controls Reference
Chronic low back pain 16.0 (51.4 to 83.4) 0.64
Acute low back pain 5.5 (69.1 to 58.1) 0.87
Time-point (eﬀects refer to the control group)
0min after Reference
3min after 29.2 (67.9 to 9.6) 0.14
5min after 52.3 (93.6 to 11.0) 0.01
10min after 79.5 (121.9 to 37.2) <0.001
Interaction terms between group and time-points (eﬀects refer to
the diﬀerence in decline as compared with the control group)
Chronic low back
pain3min
66.7 (119.9 to 13.5) 0.01
Chronic low back
pain5min
52.1 (108.9 to 4.6) 0.07
Chronic low back
pain10min
15.7 (73.8 to 42.4) 0.60
Acute low back
pain3min
67.0 (118.3 to 15.7) 0.01
Acute low back
pain5min
39.6 (94.3 to 15.1) 0.16
Acute low back
pain10min
22.6 (78.6 to 33.4) 0.43
Adjustment variables (centered)
Baseline PPTT (before
cold pressor test, per
10 kPa)
8.1 (6.9-9.4) <0.001
Withdrawal time from cold
water (per 10 s)
1.5 (4.4 to 7.5) 0.61
Age (per decade) 7.4 (24.2 to 9.4) 0.39
Female sex 56.7 (98.5 to 14.9) 0.01
BMI (per unit) 4.5 (10.1 to 1.2) 0.12
Constant 591.6 (543.8-639.3) <0.001
BMI indicates body mass index; CI, conﬁdence interval; CPM, con-
ditioned pain modulation; PPTT, pressure pain tolerance threshold.
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acute or chronic LBP as compared with controls. CPM was
still detected in both patient groups, indicating that
endogenous modulation, although eﬀective for a shorter
duration, is functioning at least partially. Accordingly, the
relevance of diminished endogenous pain control is likely to
vary greatly across patients. This stresses the need for
developing tools to detect altered endogenous modulation
in individual patients.
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